EDITORIAL
Published on 26 Sep 2024
Editorial: Insights and implications of mechanisms shaping glioma immune landscape, immunotherapy resistance, and relevant translational research
doi 10.3389/fonc.2024.1485761
- 347 views
- Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Research Topics
- Insights and Implications of Mechanisms Shaping Glioma Immune Landscape, Immunotherapy Resistance, and Relevant Translational Research
Insights and Implications of Mechanisms Shaping Glioma Immune Landscape, Immunotherapy Resistance, and Relevant Translational Research
5,002
Total downloads
17k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 28 May 2024
High expression of BTN3A1 is associated with clinical and immunological characteristics and predicts a poor prognosis in advanced human gliomas
doi 10.3389/fimmu.2024.1397486
- 1,571 views
- 3 citations
ORIGINAL RESEARCH
Published on 23 May 2024
CLEC7A regulates M2 macrophages to suppress the immune microenvironment and implies poorer prognosis of glioma
doi 10.3389/fimmu.2024.1361351
- 1,432 views
- 2 citations
ORIGINAL RESEARCH
Published on 21 Aug 2023
Knowledge structure and hotspots research of glioma immunotherapy: a bibliometric analysis
doi 10.3389/fonc.2023.1229905
- 1,590 views
- 1 citation
ORIGINAL RESEARCH
Published on 11 Aug 2023
A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma
doi 10.3389/fonc.2023.1192448
- 7,264 views
- 5 citations
ORIGINAL RESEARCH
Published on 05 Jun 2023
A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma
doi 10.3389/fonc.2023.1176448
- 2,168 views
- 7 citations
Published in
Frontiers in Oncology
Cancer Immunity and Immunotherapy
Cancer Molecular Targets and Therapeutics
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore